ESR1 and breast carcinoma: In contrast to ER + breast cancer, there was an unexpected disconnection between pnSTING and immune cell infiltration in ER- disease, as well as reversal in the prognostic ability of the pnSTINGlow signature in independent ER- datasets (Supplementary Fig. 5d–f).